Bacteremia in The Red Blood Cells Obtained from The Cell Saver in Patients Submitted to Heart Surgery
The microbiological characteristics of the red blood cells obtained after processing autologic blood recovered with the cell saver during heart surgery are of GRAM+ bacterial origin, the most isolated species being Staphylococcus epidermidis.
Anticoagulation in Pediatric Extracorporeal Life Support—Time for a More Direct Approach?
Difficulties with UF each include significant in vivo intrapatient and interpatient variability as well as achieving clinical efficacy with a reliable in vitro anticoagulation test.
Comparative Changes of Pre-Operative Autologous Transfusions and Peri-Operative Cell Salvage in The United States
There was a significant decrease in PAD red blood cell transfusions, while PACS has increased and subsequently decreased; PACS plays an important role in surgical blood conservation.
The Impact of Intraoperative Patient Blood Management on Quality Development in Cardiac Surgery
Real-time laboratory recommendations achieved a high acceptance rate early after initiation. Improvement of clinical outcome by intraoperative PBM adds to the optimized surgical care. However, the corridor between hemostatic optimization and thromboembolic risk may be narrow.
Use of Factor VIIa and Anti-inhibitor Coagulant Complex in Pediatric Cardiac Surgery Patients
Both rFVIIa and FEIBA reduced blood product usage in pediatric patients following cardiac procedures.
The Use of Hemostatic Blood Products in Children Following Cardiopulmonary Bypass and Associated Outcomes
Larger studies should be performed to determine the hemostatic efficacy of these products, as well as to clarify associated morbidities, in order to inform proper blood management.
Fibrinolysis and the Influence of Tranexamic Acid Dosing in Cardiac Surgery
The assessment of the fibrinolytic status may have the potential to facilitate dose-adjusted antifibrinolytic therapy in the future.
Sickle Cell-Related Complications in Patients Undergoing Cardiopulmonary Bypass
In this cohort of patients, older age, longer CPB times, lower median temperature, and the utilization of deep hypothermic circulatory arrest appear to play an important role in the development of complications.
Thromboelastography Profiles of Critically Ill Patients With Coronavirus Disease 2019
A large proportion of critically ill patients with coronavirus disease 2019 have hypercoagulable thromboelastography profiles with additional derangements related to fibrinogen and platelet function. As the majority of patients have an elevated thromboelastography maximum amplitude, a follow-up study evaluating platelet aggregation would be instructive.
A Pharmacokinetic and Pharmacodynamic Investigation of an ε-Aminocaproic Acid Regimen Designed for Cardiac Surgery with Cardiopulmonary Bypass
This regimen provided maximum EACA concentrations near the time of protamine administration, with a total perioperative dose of 15 g.
Blood Management in A Patient with Anti-Oka Antibody Who Underwent Cardiac Surgery Using Cardiopulmonary Bypass: A Case Report
Multidisciplinary intraoperative blood management in a patient with anti-Oka antibody facilitated successful cardiac surgery using CPB, along with effective use of limited blood products.
Effect of Antithrombin in Fresh Frozen Plasma on Hemostasis After Cardiopulmonary Bypass Surgery
Fresh frozen plasma administration increased antithrombin activity and caused activated clotting time prolongation, but then increased clotting ability. Thus, testing by rotational thromboelastometry after cardiopulmonary bypass could be valuable in the detection of comprehensive clotting ability.